Now Enrolling Children Ages 6–17 with Migraine Attacks
We’re enrolling children (ages 6–17) experiencing migraine headaches for a clinical research study.
This study is evaluating an investigational medication as a potential treatment for preventing migraine attacks in children.
Eligibility Criteria
Your child may qualify if they:
Are between 6 and 17 years old
Have been diagnosed with migraine headaches for at least 6 months
Experience 4–14 migraine headache days per month
What Participants Receive
Qualified participants will receive:
Care by a team of experienced doctors and nurses
Study-related visits, assessments, and investigational medication at no cost
Compensation for time and travel
No health insurance required
Benefits of Participation
Study care at no cost
Dedicated medical staff
Help advance pediatric migraine treatment
Join a local research study
